Population pharmacokinetics of dapsone administered biweekly to human immunodeficiency virus-infected patients.

The population pharmacokinetics of dapsone were examined in human immunodeficiency virus-infected patients receiving dapsone at a dosage of 100 mg twice weekly for the prevention of Pneumocystis carinii pneumonia. Nonlinear mixed-effect modeling was used to determine the best pharmacostatistical mod...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gatti, G, Merighi, M, Hossein, J, Travaini, S, Casazza, R, Karlsson, M, Cruciani, M, Bassetti, D
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 1996
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC163614/
https://ncbi.nlm.nih.gov/pubmed/9124833
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak